Vuagniaux; Gregoire

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vuagniaux; Gregoire.The latest application filed is for "combination product for the treatment of cancer".

Company Profile

0.12.13

Vuagniaux; Gregoire - Lausanne CH
Vuagniaux; Gregoire - Lusanne CH
Vuagniaux; Gregoire - Vaud CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Product For The Treatment Of Cancer App 20220096436 - Szyldergemajn Altman; Sergio Adrian ; et al.	2022-03-31
Combination Treatment Of Hiv Infections App 20220016079 - Vuagniaux; Gregoire ; et al.	2022-01-20
Combination Product For The Treatment Of Cancer App 20210198365 - Vuagniaux; Gregoire ; et al.	2021-07-01
Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule App 20210093645 - Vuagniaux; Gregoire ; et al.	2021-04-01
Medicament for treatment of diabetic foot infections Grant 10,751,351 - Vuagniaux , et al. A	2020-08-25
Medicament For Treatment Of Diabetic Foot Infections App 20190054100 - Vuagniaux; Gregoire ; et al.	2019-02-21
Near full-genome assay of HCV drug resistance Grant 8,911,934 - Vuagniaux , et al. December 16, 2	2014-12-16
Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events Grant 8,889,629 - Scalfaro , et al. November 18, 2	2014-11-18
Near Full-genome Assay Of Hcv Drug Resistance App 20140187765 - Vuagniaux; Gregoire ; et al.	2014-07-03
Cycloundecadepsipeptide compounds and use of said compounds as a medicament Grant 8,501,683 - Wenger , et al. August 6, 2	2013-08-06
Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy Grant 8,450,281 - Bernardi , et al. May 28, 2	2013-05-28
Use of selected cyclosporins for the treatment of hepatitis C infection Grant RE43,371 - Scalfaro , et al. May 8, 2	2012-05-08
Cycloundecadepsipeptide Compounds And Use Of Said Compounds As A Medicament App 20110212057 - Wenger; Roland ; et al.	2011-09-01
Near Full-genome Assay Of Hcv Drug Resistance App 20100311038 - Vuagniaux; Gregoire ; et al.	2010-12-09
Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin Grant 7,772,184 - Scalfaro , et al. August 10, 2	2010-08-10
Non-immunosuppressive Cyclosporin For Treatment Of Ullrich Congenital Muscular Dystrophy App 20100041593 - Bernardi; Paolo ; et al.	2010-02-18
Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin App 20090081164 - Scalfaro; Pietro ; et al.	2009-03-26
Use Of A Cyclic Undecapeptide For The Preparation Of A Medicament For Administration During Myocardial Ischaemic Events App 20090023640 - Scalfaro; Pietro ; et al.	2009-01-22
Use of selected cyclosporins for the treatment of hepatitis C infection Grant 7,439,227 - Scalfaro , et al. October 21, 2	2008-10-21
Use Of [D-Meala]3-[Etval]4-Cyclosporin For The Treatment Of Hepatitis C Infection And Pharmaceutical Composition Comprising Said [D-Meala]3-[Etval]4-Cyclosporin App 20080139463 - Scalfaro; Pietro ; et al.	2008-06-12
Use of selected cyclosporins for the treatment of hepatitis C infection App 20060252675 - Scalfaro; Pietro ; et al.	2006-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.